1. Home
  2. PGEN vs PLSE Comparison

PGEN vs PLSE Comparison

Compare PGEN & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$4.43

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Pulse Biosciences Inc (DE)

PLSE

Pulse Biosciences Inc (DE)

HOLD

Current Price

$15.23

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGEN
PLSE
Founded
1998
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.2B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
PGEN
PLSE
Price
$4.43
$15.23
Analyst Decision
Buy
Buy
Analyst Count
5
1
Target Price
$7.67
$22.00
AVG Volume (30 Days)
3.9M
188.7K
Earning Date
11-13-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,309,000.00
$86,000.00
Revenue This Year
$342.78
N/A
Revenue Next Year
$478.46
$1,002.94
P/E Ratio
N/A
N/A
Revenue Growth
59.20
N/A
52 Week Low
$0.67
$12.56
52 Week High
$5.23
$25.00

Technical Indicators

Market Signals
Indicator
PGEN
PLSE
Relative Strength Index (RSI) 63.38 61.15
Support Level $3.64 $13.94
Resistance Level $3.75 $14.70
Average True Range (ATR) 0.26 0.67
MACD 0.08 0.28
Stochastic Oscillator 84.62 93.62

Price Performance

Historical Comparison
PGEN
PLSE

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

Share on Social Networks: